The upregulation of piR-651, an oncogene, has been described as promoting tumour growth owing to mediation by Cyclin D1 and CDK4 (Cyclin Dependent Kinase 4) in non-small cell lung cancer [24]. The gene discussed is CDK4; the disease is non-small cell lung carcinoma.